Published in:
01-04-2016 | Editorial
Social/economic costs and health-related quality of life in patients with rare diseases in Europe
Authors:
Julio López-Bastida, Juan Oliva-Moreno, Renata Linertová, Pedro Serrano-Aguilar
Published in:
The European Journal of Health Economics
|
Special Issue 1/2016
Login to get access
Excerpt
Although there is no single commonly accepted definition worldwide for rare diseases [
1], the European Commission has agreed that rare diseases are life-threatening or chronically debilitating conditions affecting no more than 5 in 10,000 people in the European Union (EU) [
2]. Despite the low frequency of each single rare disease, it is estimated that between 5000 and 8000 rare diseases have been described, affecting 6–8 % of the population in the course of their lives, for a total number of people ranging between 27 and 36 million in the EU [
3‐
5]. …